Novel T-Cell Immunotherapies Market Size, Share & Trends Analysis Report By Type of T-cell Therapy (Activated T-cells, Virus Driven T-cells, Tregs, γδ T-cells, T-cell vaccines, and NK T-cells), By Disease Indication, Region, And Segment Forecasts, 2023-2031.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Novel T-Cell Immunotherapies Market Snapshot

Chapter 4. Global Novel T-Cell Immunotherapies Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

4.9. Clinical Trial/Pipeline Analysis

Chapter 5. Market Segmentation 1: By T-cell Therapy Type Estimates & Trend Analysis

5.1. By T-cell Therapy Type & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By T-cell Therapy Type:

5.2.1. Activated T-cells

5.2.2. Virus Driven T-cells

5.2.3. Tregs

5.2.4. γδ T-cells

5.2.5. T-cell vaccines

5.2.6. NK T-cells

Chapter 6. Market Segmentation 2: By Disease Indications Estimates & Trend Analysis

6.1. By Disease Indications & Market Share, 2020& 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Disease Indications:

6.2.1. Lung cancer

6.2.2. Breast Cancer

6.2.3. Cytomegalovirus Infection

6.2.4. Glioblastoma

6.2.5. Hepatocellular Carcinoma

6.2.6. Acute Myeloid Leukemia

6.2.7. Ovarian Cancer

6.2.8. Type 1 Diabetes Mellitus

6.2.9. Sarcoma

6.2.10. HIV infections

6.2.11. Pancreatic Cancer

6.2.12. Other Disease Indications

Chapter 7. Novel T-Cell Immunotherapies Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Novel T-Cell Immunotherapies Market revenue (US$ Million) estimates and forecasts By T-cell Therapy Type, 2020-2030

7.1.2. North America Novel T-Cell Immunotherapies Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2020-2030

7.1.3. North America Novel T-Cell Immunotherapies Market revenue (US$ Million) estimates and forecasts by country, 2020-2030

7.2. Europe

7.2.1. Europe Novel T-Cell Immunotherapies Market revenue (US$ Million) By T-cell Therapy Type, 2020-2030

7.2.2. Europe Novel T-Cell Immunotherapies Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2020-2030

7.2.3. Europe Novel T-Cell Immunotherapies Market revenue (US$ Million) by country, 2020-2030

7.3. Asia Pacific

7.3.1. Asia Pacific Novel T-Cell Immunotherapies Market revenue (US$ Million) By T-cell Therapy Type, 2020-2030

7.3.2. Asia Pacific Novel T-Cell Immunotherapies Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2020-2030

7.3.3. Asia Pacific Novel T-Cell Immunotherapies Market revenue (US$ Million) by country, 2020-2030

7.4. Latin America

7.4.1. Latin America Novel T-Cell Immunotherapies Market revenue (US$ Million) By T-cell Therapy Type, (US$ Million)

7.4.2. Latin America Novel T-Cell Immunotherapies Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2020-2030

7.4.3. Latin America Novel T-Cell Immunotherapies Market revenue (US$ Million) by country, (US$ Million) 2020-2030

7.5. Middle East & Africa

7.5.1. Middle East & Africa Novel T-Cell Immunotherapies Market revenue (US$ Million) By T-cell Therapy Type, (US$ Million)

7.5.2. Middle East & Africa Novel T-Cell Immunotherapies Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2020-2030

7.5.3. Middle East & Africa Novel T-Cell Immunotherapies Market revenue (US$ Million) by country, (US$ Million) 2020-2030

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Atara Biotherapeutics

8.2.2. AlloVir

8.2.3. Eureka Therapeutics

8.2.4. Eutilex

8.2.5. GammaDelta Therapeutics

8.2.6. NexImmune

8.2.7. OSE Immunotherapeutics

8.2.8. Tevogen Bio

8.2.9. WindMIL Therapeutics

8.2.10. Acepodia

8.2.11. Adaptate Therapeutics

8.2.12. Adicet

8.2.13. Cytomed Therapeutics

8.2.14. Gadeta

8.2.15. IN8bio

8.2.16. Kiromic Biopharma

8.2.17. Lava Therapeutics

8.2.18. Takeda Pharmaceuticals

8.2.19. TC Biopharm

8.2.20. ImCheck Therapeutics

8.2.21. Expression Therapeutics LLC

8.2.22. Triumvira Immunologics

8.2.23. PureTech Health

8.2.24. PhosphoGam

8.2.25. Caladrius Biosciences

8.2.26. Eli Lilly and Company

8.2.27. Miltenyi Biotec

8.2.28. Sangamo Therapeutics (TxCell)

8.2.29. Cellenkos Inc.

8.2.30. Pfizer Inc.

8.2.31. PolTREG S.A..

8.2.32. Parvus Therapeutics

8.2.33. ILTOO Pharma

8.2.34. Philogen S.p.A.

8.2.35. TRACT Therapeutics, Inc.

8.2.36. REGiMMUNE Co, Ltd.

8.2.37. Roche

8.2.38. Celgene

8.2.39. AHEAD THERAPEUTICS S.L.

8.2.40. Other Prominent Players

Segmentation of Novel T-Cell Immunotherapies Market

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Type of T-cell Therapy

• Activated T-cells
• Virus Driven T-cells
• Tregs
• γδ T-cells
• T-cell vaccines
• NK T-cells

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Disease Indication

• Lung cancer
• Breast Cancer
• Cytomegalovirus Infection
• Glioblastoma
• Hepatocellular Carcinoma
• Acute Myeloid Leukemia
• Ovarian Cancer
• Type 1 Diabetes Mellitus
• Sarcoma
• HIV infections
• Pancreatic Cancer
• Others

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America novel T-cell immunotherapies market revenue (US$ Million) by Country, 

• U.S.
• Canada

Europe novel T-cell immunotherapies market revenue (US$ Million) by Country, 

• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific novel T-cell immunotherapies market revenue (US$ Million) by Country,

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America novel T-cell immunotherapies market revenue (US$ Million) by Country, 

• Brazil

• Mexico
• Rest of Latin America

Middle East & Africa novel T-cell immunotherapies market revenue (US$ Million) by Country, 

• GCC Countries

• South Africa
• Rest of Middle East & Africa

Competitive Landscape

• Company Overview
• Financial Performance
• Key Development
• Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

• Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
• External and internal proprietary databases, regulatory databases, and relevant patent analysis
• Statistical databases, National government documents, and market reports
• Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

• Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
• Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
• Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
• End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.